Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 03-2020 | 03-2019 | 03-2018 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 236,000 | 259,000 | 272,000 | 151,000 | 186,000 |
| Depreciation Amortization | 175,000 | 165,000 | 176,000 | 180,000 | 174,000 |
| Income taxes - deferred | 125,000 | -19,000 | 53,000 | 70,000 | 40,000 |
| Accounts receivable | 28,000 | -165,000 | 26,000 | -32,000 | 47,000 |
| Accounts payable and accrued liabilities | 39,000 | 21,000 | 6,000 | 38,000 | 29,000 |
| Other Working Capital | -113,000 | -100,000 | -83,000 | -138,000 | -83,000 |
| Other Operating Activity | -2,000 | 235,000 | -35,000 | 8,000 | -61,000 |
| Operating Cash Flow | $488,000 | $396,000 | $415,000 | $277,000 | $332,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -132,000 | -62,000 | -83,000 | -141,000 | -188,000 |
| Net Acquisitions | -212,000 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -1,031,000 | -1,485,000 | -1,136,000 | -1,051,000 | -767,000 |
| Sale Of Investment | 1,087,000 | 1,482,000 | 1,103,000 | 984,000 | 1,104,000 |
| Purchase Sale Intangibles | -39,000 | -14,000 | -8,000 | -27,000 | -443,000 |
| Other Investing Activity | -22,000 | 0 | 4,000 | -21,000 | -434,000 |
| Investing Cash Flow | $-310,000 | $-65,000 | $-112,000 | $-229,000 | $-285,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 93,000 | N/A | N/A | N/A | N/A |
| Debt Issued | 52,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -51,000 | -304,000 | -1,000 | 290,000 | -80,000 |
| Common Stock Issued | 4,000 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -16,000 | -6,000 | -8,000 | N/A | -242,000 |
| Dividend Paid | -57,000 | -52,000 | -58,000 | -61,000 | -52,000 |
| Other Financing Activity | -29,000 | 28,000 | -241,000 | -297,000 | 317,000 |
| Financing Cash Flow | $-4,000 | $-334,000 | $-308,000 | $-68,000 | $-57,000 |
| Exchange Rate Effect | 2,000 | N/A | 1,000 | 1,000 | -8,000 |
| Beginning Cash Position | 27,000 | 30,000 | 37,000 | 58,000 | 76,000 |
| End Cash Position | 203,000 | 26,000 | 32,000 | 39,000 | 59,000 |
| Net Cash Flow | $176,000 | $-3,000 | $-5,000 | $-19,000 | $-17,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 488,000 | 396,000 | 415,000 | 277,000 | 332,000 |
| Capital Expenditure | -133,000 | -64,000 | -101,000 | -143,000 | -189,000 |
| Free Cash Flow | 355,000 | 332,000 | 314,000 | 134,000 | 143,000 |